In the seven samples with evolutionary bottlenecks, increased chr3q (PIK3CA), chr8p (MYC, CCNE2) and 20q (ZNF217, AURKA) gains were found in the persistent subclones in recurrent tumors comparing to primary DCIS. The gene discussed is PIK3CA; the disease is ductal breast carcinoma in situ.